Skip to main content

Peer Review reports

From: CERCAM is a prognostic biomarker associated with immune infiltration of macrophage M2 polarization in head and neck squamous carcinoma

Original Submission
22 Mar 2023 Submitted Original manuscript
3 Aug 2023 Reviewed Reviewer Report - Pijush Das
17 Aug 2023 Reviewed Reviewer Report - Muzafar A. MacHa
11 Sep 2023 Author responded Author comments - Xiao-Jian Chen
Resubmission - Version 2
11 Sep 2023 Submitted Manuscript version 2
15 Sep 2023 Author responded Author comments - Xiao-Jian Chen
Resubmission - Version 3
15 Sep 2023 Submitted Manuscript version 3
Publishing
18 Sep 2023 Editorially accepted
7 Oct 2023 Article published 10.1186/s12903-023-03421-0

You can find further information about peer review here.

Back to article page